<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Amaurosis fugax (transient monocular or binocular visual loss)
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Amaurosis fugax (transient monocular or binocular visual loss)
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Amaurosis fugax (transient monocular or binocular visual loss)
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Syndee Givre, MD, PhD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Gregory P Van Stavern, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jonathan Trobe, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Janet L Wilterdink, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            May 04, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION AND DEFINITIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Amaurosis fugax (from the Greek "amaurosis," meaning dark, and the Latin "fugax," meaning fleeting) refers to a transient loss of vision in one or both eyes [
         <a href="#rid1">
          1
         </a>
         ]. Varied use of common terminology may cause some confusion when reading the literature. Some suggest that "amaurosis fugax" implies a vascular cause for the visual loss [
         <a href="#rid2">
          2
         </a>
         ], but the term continues to be used when describing visual loss from any origin and involving one or both eyes. The term "transient monocular blindness" is also often used but is not ideal, since most patients do not experience complete loss of vision with the episode [
         <a href="#rid3">
          3
         </a>
         ]. "Transient monocular visual loss" (TMVL) and "transient binocular visual loss" (TBVL) are preferred to describe abrupt and temporary loss of vision in one or both eyes, since they carry no connotation regarding etiology.
        </p>
        <p>
         Transient visual loss (TVL), either monocular or binocular, reflects a heterogeneous group of disorders, some relatively benign and others with grave neurologic or ophthalmologic implications. The task of the clinician is to use the history and examination to localize the problem to a region in the visual pathways, identify potential etiologies, and, when indicated, perform a focused battery of laboratory tests to confirm or exclude certain causes. Therapeutic interventions and prognostic implications are specific to the underlying cause.
        </p>
        <p>
         This topic discusses TVL. Other ocular and cerebral ischemic syndromes are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5236.html" rel="external">
          "Central and branch retinal artery occlusion"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1102.html" rel="external">
          "Posterior circulation cerebrovascular syndromes"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          APPROACH TO TRANSIENT VISUAL LOSS
         </span>
         <span class="headingEndMark">
          —
         </span>
         By definition, patients with transient visual loss (TVL) almost always present after the episode has resolved; hence, the neurologic and ophthalmologic examination is usually normal. Reliance is placed on the patient's description of the nature of the visual symptoms and associated features  (
         <a class="graphic graphic_table graphicRef64994" href="/z/d/graphic/64994.html" rel="external">
          table 1
         </a>
         ). Pertinent medical and family history may also provide valuable clues to the underlying diagnosis.
        </p>
        <p>
         Few case series of patients with TVL are reported. Details from the Framingham cohort provide some interesting insights into the challenges of evaluating this symptom. Between 1971 and 1989, participants were systematically questioned regarding specific symptoms of transient ischemic attack (TIA) and stroke; 186 of 2110 subjects reported onset of a sudden visual deficit (not necessarily transient) [
         <a href="#rid4">
          4
         </a>
         ]. Follow-up evaluation determined the underlying cause to be stroke or TIA (24 percent), ocular disease (17 percent), transient monocular blindness (10 percent), and migraine (14 percent). The cause remained unknown in 22 percent, and a miscellany of etiologies comprised the remaining 12 percent.
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Historical features
         </span>
         <span class="headingEndMark">
          —
         </span>
         Important historical features include whether the visual loss affected one or both eyes, the duration of the episode, and a specific description of the symptoms.
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h3">
          Monocular versus binocular
         </span>
         <span class="headingEndMark">
          —
         </span>
         It is important, but often difficult, to establish whether the visual loss was monocular or binocular. Transient monocular visual loss (TMVL) implies a disorder anterior to the optic chiasm (ie, the eye or the optic nerve); possibilities include ocular disease as well as ischemia due to ipsilateral carotid artery disease. Transient binocular visual loss (TBVL) suggests a more posterior process, involving the optic chiasm, tracts, or radiations, or the visual cortex.
        </p>
        <p>
         Patients with homonymous visual field defects often report monocular visual loss and attribute it to the eye with the temporal field cut. The patient should be asked specifically whether each eye was alternately covered during the attack. Impairment of reading suggests that the visual loss was binocular rather than monocular [
         <a href="#rid3">
          3
         </a>
         ]. In practice, many patients are not able to state definitively whether the episode affected one or both eyes [
         <a href="#rid5">
          5
         </a>
         ]. When the history is unclear, the clinician should assume that either a monocular or binocular etiology is possible.
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h3">
          Duration
         </span>
         <span class="headingEndMark">
          —
         </span>
         Transient visual obscurations due to papilledema typically last seconds. Thromboembolic events from carotid disease or elsewhere generally last 1 to 15 minutes and only rarely an hour or more [
         <a href="#rid6">
          6-8
         </a>
         ]. Migraine aura typically lasts 10 to 30 minutes.
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h3">
          Description of visual symptoms
         </span>
         <span class="headingEndMark">
          —
         </span>
         TVL from any cause can be described as mild blurring or fogging to complete blackness and may involve a part of or all of the visual field. As an example, patients with ocular ischemia may lose the upper or lower half of vision, the temporal or nasal aspect of vision, small areas of vision centrally or paracentrally, and the entire visual field [
         <a href="#rid6">
          6,9,10
         </a>
         ]. TMVL descending over the field of vision (like a curtain or shade) or, less commonly, ascending from below, is highly suggestive of retinal ischemia [
         <a href="#rid6">
          6,9,10
         </a>
         ].
        </p>
        <p>
         Positive visual phenomena, such as photopsias or scintillations that march across the visual field, suggest migraine as the most likely diagnosis. Seizures affecting visual cortex often involve positive visual symptoms but are typically maximal at onset and lack the evolution or build-up characteristic of migraine. While the visual symptoms produced by retinal ischemia are usually "negative" (eg, shaded, black, blurred), positive symptoms are also known to occur in this setting [
         <a href="#rid6">
          6,11,12
         </a>
         ]. Similarly, migraine can produce visual loss without scintillations [
         <a href="#rid13">
          13,14
         </a>
         ]. Patients who experience intermittent hyphema (hemorrhage within the anterior chamber) may remark that the visual field appears red (erythropsia) during the episodes [
         <a href="#rid15">
          15
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h3">
          Precipitating factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Severe carotid occlusive disease has been associated with dimming of vision in one eye after exposure to bright light (retinal claudication) [
         <a href="#rid6">
          6,12,16-18
         </a>
         ]. Alternating TVL to bright light has also been described in two patients with giant cell arteritis (GCA) [
         <a href="#rid19">
          19
         </a>
         ]. Other retinal diseases (eg, photoreceptor dystrophy, macular degeneration) are also associated with transient worsening of vision in bright light. The mechanism is believed to be related to an ischemia-induced delay in regenerating visual pigments in the photoreceptors [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p>
         Episodes of TMVL due to carotid stenosis may be induced by changes in posture or neck position that temporarily reduce blood flow through the artery [
         <a href="#rid12">
          12
         </a>
         ]. Postprandial TMVL has been described in severe carotid narrowing, presumably as a vascular steal phenomenon [
         <a href="#rid16">
          16,20
         </a>
         ].
        </p>
        <p>
         TMVL occurring when the eye is moved into certain positions of gaze (gaze-evoked amaurosis) is suggestive of an orbital mass and is thought to be due to interruption of blood flow to the retina, choroid, or optic nerve [
         <a href="#rid21">
          21
         </a>
         ].
        </p>
        <p>
         Loss of vision after exercise or a hot shower (Uhthoff symptom) is characteristic of demyelinating disease of the optic nerve. Exercise has also been reported to induce retinal vasospasm [
         <a href="#rid22">
          22,23
         </a>
         ].
        </p>
        <p>
         The transient visual obscurations of papilledema are sometimes brought on by postural change, exercise, or muscular straining.
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h3">
          Recurrence
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with TVL from vasospasm, migraine, or ischemia may have multiple episodes separated by minutes or years. In one study, a high number of recurrent episodes (&gt;10) of TMVL was more likely to be associated with complete rather than incomplete or absent occlusion of the ipsilateral internal carotid artery [
         <a href="#rid6">
          6
         </a>
         ]. However, multiple, stereotypic episodes of TMVL recurring over many years in the absence of stroke or permanent visual loss would suggest a more benign etiology such as migraine or vasospasm.
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h3">
          Associated symptoms
         </span>
         <span class="headingEndMark">
          —
         </span>
         TVL due to thromboembolic disease is painless in the vast majority of patients. The association of TVL with headache or periocular pain should alert the examiner to check for other causes such as migraine, angle closure glaucoma, and GCA.
        </p>
        <p>
         The association of TVL with transient contralateral hemiplegia is strongly suggestive of severe carotid occlusive disease [
         <a href="#rid7">
          7,20
         </a>
         ]. Vertebrobasilar symptoms (vertigo, dysarthria, diplopia) should suggest posterior circulation ischemia. Visual loss in the latter setting is binocular, but patients may misreport a transient hemianopia as monocular vision loss.
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h3">
          Medical history
         </span>
         <span class="headingEndMark">
          —
         </span>
         Older age, a medical history of diabetes mellitus, hypertension, or hyperlipidemia all suggest atherosclerotic vascular disease. Known cardiac disease might indicate a cardioembolic event. A history of rash and previous miscarriage is a feature of the antiphospholipid antibody syndrome, which may uncommonly cause TVL. A family history of stroke at a young age or unexplained thrombosis might prompt evaluation for an underlying hereditary hypercoagulable disorder. A history of typical migraine headaches in the patient or family member suggests migraine as a cause.
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         The examination should include testing of visual acuity and visual fields, and examination of the optic fundus. The techniques employed are discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/5095.html" rel="external">
          "The detailed neurologic examination in adults", section on 'Vision (CN II)'
         </a>
         .)
        </p>
        <p>
         Funduscopic examination should include careful observation of the optic disc, retina, and blood vessels for clues as to the origin of the visual symptoms:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Disc swelling in the setting of TMVL suggests an acute event involving the optic nerve, usually ischemia or inflammation. Because optic disc pallor does not develop until four to six weeks after an injury, its presence suggests a subacute or chronic process, rather than an acute event. Bilateral disc swelling with good visual acuity should prompt an evaluation for papilledema. (See
         <a class="medical medical_review" href="/z/d/html/5241.html" rel="external">
          "Overview and differential diagnosis of papilledema"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Retinal whitening often reflects ischemia of the inner retina, and may be seen after a branch or central retinal artery occlusion  (
         <a class="graphic graphic_picture graphicRef60171" href="/z/d/graphic/60171.html" rel="external">
          picture 1
         </a>
         ). Mid-peripheral hemorrhages, tortuous veins, and neovascularization reflect reduced retinal arterial flow and venous stasis as the result of severe carotid stenosis. (See
         <a class="medical medical_review" href="/z/d/html/5236.html" rel="external">
          "Central and branch retinal artery occlusion"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Examination of the arterioles should focus on caliber as well as the presence of embolic plaques. Investigators have attempted to identify the origin of retinal plaques by their appearance, but in practice the distinction is often difficult. A Hollenhorst plaque typically appears at vascular bifurcations, and has a highly refractile appearance  (
         <a class="graphic graphic_picture graphicRef63740" href="/z/d/graphic/63740.html" rel="external">
          picture 2
         </a>
         ). It strongly suggests ipsilateral carotid artery disease, but these cholesterol emboli may also arise from a more proximal source, such as the aortic arch [
         <a href="#rid24">
          24
         </a>
         ]. Platelet-fibrin and calcific emboli are less commonly seen.
        </p>
        <p>
        </p>
        <p>
         A detailed eye examination usually requires an ophthalmology consult, which is indicated in many cases of TVL. (See
         <a class="local">
          'Diagnostic evaluation of transient visual loss'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h1">
          CAUSES OF TRANSIENT MONOCULAR VISUAL LOSS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ischemia is the most common cause of transient monocular visual loss (TMVL) [
         <a href="#rid5">
          5
         </a>
         ]; this in itself can have diverse etiologies. Papilledema, optic neuropathy, and ocular disease are other causes of TMVL.
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h2">
          Ischemia
         </span>
        </p>
        <p class="headingAnchor" id="H1777682226">
         <span class="h3">
          Common features
         </span>
         <span class="headingEndMark">
          —
         </span>
         The pathogenesis and pathophysiology for TMVL of ischemic origin are diverse and include large artery occlusive disease (atherothrombosis, embolus, dissection), small artery occlusive disease (anterior ischemic optic neuropathy, vasculitis), venous disease, cardiac disease, hypercoagulable disorders, and systemic hypoperfusion. The final common pathway for these disorders is ischemia to the retina, the optic nerve, or both. TMVL secondary to retinal ischemia from carotid disease may be due to either embolism or hypoperfusion from fixed arterial stenosis, whereas optic nerve ischemia usually results from the latter mechanism.
        </p>
        <p>
         Most patients with TMVL attributable to ischemia will report areas of blank or fuzzy vision ("negative visual phenomena"). Less common, but not unusual, are reports of positive visual phenomena. Symptoms generally begin abruptly and reach maximum severity within the first few minutes.
        </p>
        <p>
         Funduscopic examination may be normal or may show evidence of vascular disease: cotton wool spots, retinal emboli, retinal hemorrhages, retinal whitening, or dilated retinal veins  (
         <a class="graphic graphic_picture graphicRef60171" href="/z/d/graphic/60171.html" rel="external">
          picture 1
         </a>
         and
         <a class="graphic graphic_picture graphicRef63740" href="/z/d/graphic/63740.html" rel="external">
          picture 2
         </a>
         ).
        </p>
        <p>
         Retinal embolism is frequently asymptomatic. In a population-based study of approximately 2000 older adults (≥49 years) whose retinas were examined at 5 and 10 years, there was a baseline prevalence of retinal emboli of 1.4 percent [
         <a href="#rid25">
          25
         </a>
         ]. The cumulative 10-year incidence was 3 percent. Over 10 years of follow-up, all-cause and stroke-related mortality was somewhat higher in patients with documented retinal emboli (hazard ratio [HR] 1.3, CI 1.0-1.8) [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h3">
          Carotid artery disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ischemic visual loss related to occlusive disease in the cervical carotid artery may result from thromboembolism or hypoperfusion [
         <a href="#rid9">
          9,11
         </a>
         ]. The former mechanism is believed to be more common [
         <a href="#rid13">
          13,27
         </a>
         ].
        </p>
        <p>
         In contrast with transient ischemic attacks (TIAs) involving the cerebral hemispheres, retinal ischemia is more commonly associated with emboli originating from carotid stenosis rather than heart disease [
         <a href="#rid5">
          5,28-30
         </a>
         ]. This may represent a streaming effect of laminar blood flow, whereby particulates of uniform size are consistently deposited into one lamina and swept into the same distal vascular bed. Small emboli from carotid disease may be more likely to drift to the edge of the bloodstream and enter the ophthalmic artery. Also, these small particles may be more prone to obstruct the smaller retinal arterioles.
        </p>
        <p>
         Severe stenosis (90 to 100 percent) of the ipsilateral carotid artery may also cause visual loss due to retinal and/or choroidal hypoperfusion from flow limiting stenosis. This ischemic mechanism may be more likely to include positive visual phenomena and recurrent episodes than thromboembolism, and it is often induced by activities that reduce ocular perfusion pressure (such as postural change, postprandial vascular steal) or increase retinal oxygen demand (such as exposure to bright light) [
         <a href="#rid6">
          6,9,12,18,20,27
         </a>
         ]. By contrast, episodes of TMVL due to carotid artery thromboembolism usually occur spontaneously, and are more often isolated events, although they can recur [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p>
         Visual loss caused by either mechanism typically encompasses the entire visual field, but may affect only the upper, lower, nasal, or temporal portion [
         <a href="#rid2">
          2,8,9,11
         </a>
         ]. Small central or paracentral scotomas can also occur [
         <a href="#rid9">
          9
         </a>
         ]. The classic description of a "curtain" or "shade" descending over vision is relatively uncommon; in one large study, only 23.8 percent of patients with TMVL experienced altitudinal visual loss [
         <a href="#rid31">
          31
         </a>
         ]. Nonetheless, when this is described, it is highly suggestive of retinal embolism [
         <a href="#rid32">
          32
         </a>
         ]. Patients may also experience gradual graying of vision that progresses from the periphery to the center [
         <a href="#rid11">
          11,12,32
         </a>
         ]. The visual loss may be associated with scintillations or the sensation of color [
         <a href="#rid9">
          9,13
         </a>
         ]. Episodes generally last from seconds to minutes, rarely more than 15 minutes [
         <a href="#rid2">
          2,6,8,9,11
         </a>
         ].
        </p>
        <p>
         When contralateral hemispheric symptoms (motor, sensory, aphasia) accompany visual loss, carotid disease is very likely; however, TMVL is more often an isolated symptom [
         <a href="#rid5">
          5,7
         </a>
         ].
        </p>
        <p>
         In a prospective study of 337 patients with TMVL, clinical features most predictive of high-grade (&gt;70 percent) carotid stenosis included rapid onset of symptoms, altitudinal pattern of onset or resolution, and a duration of 1 to 10 minutes [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p>
         The diagnosis of carotid disease in the setting of TMVL is important because of the implications for stroke risk, approximately 2 to 3 percent per year [
         <a href="#rid33">
          33
         </a>
         ]. Most of these strokes are large-vessel infarcts within the territory of the ipsilateral carotid artery [
         <a href="#rid34">
          34
         </a>
         ]. Compared with cerebral ischemia, TMVL carries a lower risk for stroke in the setting of high-grade carotid disease but still identifies a high-risk population for which carotid endarterectomy may be beneficial, particularly in high-risk subgroups [
         <a href="#rid30">
          30,35
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1106.html" rel="external">
          "Management of symptomatic carotid atherosclerotic disease", section on 'Factors influencing benefit and risk'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h3">
          Giant cell arteritis
         </span>
         <span class="headingEndMark">
          —
         </span>
         TMVL, similar in character to that associated with carotid disease, can occur in patients with giant cell arteritis (GCA) [
         <a href="#rid36">
          36,37
         </a>
         ]. Occlusion or near occlusion of the posterior ciliary arteries by granulomatous inflammation within the artery wall can cause an anterior ischemic optic neuropathy. Posterior ischemic optic neuropathy and central retinal artery occlusion are also manifestations of GCA.
        </p>
        <p>
         GCA most often presents as acute sustained unilateral visual loss with a swollen optic disc [
         <a href="#rid36">
          36
         </a>
         ]. In two large series (each &gt;150 patients) of biopsy-confirmed GCA, transient visual loss (TVL) was the presenting symptom in just 10 to 15 percent [
         <a href="#rid36">
          36,38
         </a>
         ]. It was bilateral in 27 to 35 percent of these. Common accompanying symptoms include jaw claudication and headache (each in approximately half of patients). Anemia and thrombocytosis are also common in patients with GCA. However, patients with occult GCA may have no other symptoms [
         <a href="#rid37">
          37
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8225.html" rel="external">
          "Clinical manifestations of giant cell arteritis"
         </a>
         .)
        </p>
        <p>
         While TVL is a relatively uncommon presentation for GCA, it represents an opportunity for intervention to prevent permanent visual loss. (See
         <a class="medical medical_review" href="/z/d/html/8240.html" rel="external">
          "Treatment of giant cell arteritis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h3">
          Other causes of ischemia
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cardiogenic embolism – Emboli from the heart and great vessels may lodge in the ophthalmic circulation and cause TMVL, which is clinically similar to that associated with carotid disease. Cardiogenic embolism is less likely to underlie TMVL than a cerebral TIA [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         While an uncommon cause of TMVL, cardiogenic embolism is important to identify in this setting, because anticoagulation is often recommended to prevent more serious sequelae. A detailed review of cardiogenic sources of emboli is presented elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/1089.html" rel="external">
          "Stroke: Etiology, classification, and epidemiology", section on 'Embolism'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hypotension – Hypoperfusion from cardiac failure and hypovolemia, reduced cardiac output from a dysrhythmia, and orthostatic hypotension may cause TVL [
         <a href="#rid11">
          11-13,27
         </a>
         ]. Anemia and intradialysis hypotension have also been implicated [
         <a href="#rid39">
          39,40
         </a>
         ]. In this setting, visual loss is usually binocular and associated with other suggestive features, such as postural change, lightheadedness, and presyncope. However, orthostatic or systemic hypotension can result in hypoperfusion to one eye, usually in association with carotid occlusive disease, which results in selective hypoperfusion to the ipsilateral eye [
         <a href="#rid41">
          41,42
         </a>
         ]. TMVL may also be precipitated by hypotension in the setting of underlying retinopathy, optic neuropathy, or glaucoma [
         <a href="#rid40">
          40,43,44
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Coagulopathy – Patients with coagulation disorders may have episodes of TMVL, with characteristics similar to those caused by atheromatous disease [
         <a href="#rid43">
          43,45,46
         </a>
         ]. Patients with coagulopathies usually have other symptoms in addition to TMVL (eg, rash associated with the antiphospholipid antibody syndrome) and/or a medical history of other coagulation-related problems. However, there have been reports of patients with TMVL as the presenting symptom of a coagulation disorder [
         <a href="#rid46">
          46,47
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Others – Nonarteritic anterior ischemic optic neuropathy is more common than GCA and is associated with small artery disease. However, it is not typically preceded by transient episodes of visual loss, and therefore is not usually considered in the differential diagnosis of TMVL [
         <a href="#rid47">
          47,48
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5256.html" rel="external">
          "Nonarteritic anterior ischemic optic neuropathy: Clinical features and diagnosis", section on 'Presenting symptoms'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Atherosclerosis involving the intracranial carotid or the ophthalmic artery may also produce TMVL [
         <a href="#rid49">
          49
         </a>
         ]. TMVL also occurs in nonatheromatous disease of the carotid, such as fibromuscular dysplasia, aneurysm, dissection, and arteritis, such as granulomatosis with polyangiitis and Takayasu arteritis [
         <a href="#rid27">
          27,50
         </a>
         ]. Cocaine and other illicit drugs have been associated with TMVL through vasospasm or other mechanisms [
         <a href="#rid51">
          51-53
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h2">
          Retinal vein occlusion
         </span>
         <span class="headingEndMark">
          —
         </span>
         TMVL may occur as a premonitory symptom of central retinal vein occlusion [
         <a href="#rid11">
          11,54,55
         </a>
         ]. Occlusion or thrombosis of the central retinal vein is associated with chronic glaucoma, atherosclerotic risk factors (age, diabetes, hypertension), hyperviscosity, and coagulopathy [
         <a href="#rid56">
          56-58
         </a>
         ]. The cause of retinal vein occlusion is often unknown.
        </p>
        <p>
         Episodes of visual loss are quite variable in length and may last several hours. Another potentially distinguishing feature is the description of "cloudy vision" rather than visual loss; however, episodes may be entirely similar to those occurring in arterial ischemia [
         <a href="#rid55">
          55,57
         </a>
         ]. It is more common, however, for retinal vein occlusion to have a subacute presentation of fixed vision loss.
        </p>
        <p>
         Some speculate that venous congestion and/or reflux may also play a role in some cases of idiopathic TMVL. (See
         <a class="local">
          'Idiopathic'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h2">
          Retinal vasospasm and retinal migraine
         </span>
         <span class="headingEndMark">
          —
         </span>
         Idiopathic, reversible vasospasm affecting blood vessels in the retina and causing TMVL is a commonly described but poorly understood and somewhat controversial phenomenon. Reported observations include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Studies of children, adolescents, and young adults with TMVL have shown that a majority have headaches either associated with or between episodes, a personal or family history of migraines, and a benign course [
         <a href="#rid2">
          2,4,59,60
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Transient arterial narrowing has been observed in retinal arteries in symptomatic patients [
         <a href="#rid61">
          61-64
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Some patients' symptoms respond to calcium channel blockers [
         <a href="#rid62">
          62-64
         </a>
         ]
        </p>
        <p>
        </p>
        <p>
         Some of these observations have led to this entity being called retinal migraine. Retinal migraine is a diagnosis included in the International Headache Society Criteria [
         <a href="#rid65">
          65
         </a>
         ], but is a debatable entity, and is always considered a diagnosis of exclusion. The formal criteria require reversible positive or negative visual phenomena accompanied or followed within 60 minutes by migraine headache. A personal or family history of migraine may suggest the diagnosis in the absence of headache. In general, migraine as a cause of TVL is best accepted as a manifestation of occipital cortex involvement, producing binocular, usually positive, visual symptoms, the "classic" or typical migraine aura. The etiology in this case is presumed to be a cortical spreading depression and not vasospasm. (See
         <a class="local">
          'Migraine'
         </a>
         below.)
        </p>
        <p>
         Important caveats in the diagnosis of retinal vasospasm are that not all arterial narrowing is vasospasm; proximal occlusive disease and low blood flow may also give this appearance. Also, vasospasm may occur secondary to an underlying disease, such as vasculitis, migraine, hypercoagulability, or cocaine use [
         <a href="#rid13">
          13,36,51,66,67
         </a>
         ].
        </p>
        <p>
         Symptoms described in retinal vasospasm include characteristic positive phenomena of scintillations and photopsias as well as primarily negative symptoms: black, gray, white, or shaded areas, which are indistinguishable from ischemic symptoms. Patients may have several episodes in one day. A typical episode lasts longer than 5 minutes and less than 60 minutes. A first episode usually occurs in individuals less than 40 years old.
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h2">
          Optic neuropathy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with a chronic optic neuropathy will occasionally complain of episodes of transient loss or blurring of vision, usually in association with elevation of body temperature (hot shower, exercise). This phenomenon is termed "Uhthoff symptom" and reflects temporary conduction block along a previously demyelinated optic nerve [
         <a href="#rid68">
          68,69
         </a>
         ].
        </p>
        <p>
         The episodes typically last several minutes, but occasionally longer, until the body temperature returns to normal. Uhthoff phenomenon is classically associated with multiple sclerosis, but has been reported in other optic neuropathies [
         <a href="#rid70">
          70
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1689.html" rel="external">
          "Manifestations of multiple sclerosis in adults", section on 'Visual symptoms'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1689.html" rel="external">
          "Manifestations of multiple sclerosis in adults", section on 'Heat sensitivity'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h2">
          Papilledema
         </span>
         <span class="headingEndMark">
          —
         </span>
         While rarely the presenting symptom, transient visual obscurations are common in patients with papilledema. These are described as a "whiting" or "graying out" of part or all of the visual field; they are often unilateral, and typically very brief (just seconds) [
         <a href="#rid41">
          41,71,72
         </a>
         ]. They may occur spontaneously or with changes in position, and they are believed to represent transient fluctuations in nerve head perfusion. Other symptoms and signs (eg, headache, bilateral disc swelling) are usually present to suggest this diagnosis. (See
         <a class="medical medical_review" href="/z/d/html/5257.html" rel="external">
          "Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5241.html" rel="external">
          "Overview and differential diagnosis of papilledema"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H21">
         <span class="h2">
          Optic nerve compression
         </span>
         <span class="headingEndMark">
          —
         </span>
         Gaze-evoked amaurosis has been described in association with compressive optic neuropathies from tumors, trauma, Graves' ophthalmopathy, and other causes [
         <a href="#rid73">
          73,74
         </a>
         ]. In cases due to slow-growing masses, the examination will often reflect ipsilateral optic nerve dysfunction.
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h2">
          Ocular causes
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ocular causes of TMVL include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Increased intraocular pressure such as from intermittent angle closure glaucoma is typically associated with eye pain [
         <a href="#rid44">
          44,75
         </a>
         ]. A complaint of halos around lights is common in this condition.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Spontaneous hyphema (hemorrhage within the anterior chamber) can occur after cataract surgery with lens implantation [
         <a href="#rid13">
          13,15,76
         </a>
         ]. The symptoms of the hyphema may be visual loss and erythropsia.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Vitreous floaters occasionally obscure central vision.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Congenital optic disc anomalies and optic disc drusen have been associated with TMVL.
        </p>
        <p>
        </p>
        <p>
         Clues to an ocular cause might include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Eye redness
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pain and tearing associated with visual loss (intermittent angle closure glaucoma)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         More prolonged episodes [
         <a href="#rid3">
          3
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Relief of symptoms with blinking or rubbing the eye (dry eye)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Squinting (refractive error)
        </p>
        <p>
        </p>
        <p>
         TMVL has been reported to occur in persons after viewing a smartphone screen in a darkened room while lying on one side [
         <a href="#rid77">
          77
         </a>
         ]. This apparently benign phenomenon, which has been reproduced in previously asymptomatic persons, is believed to result because the two eyes become differentially adapted to light. When the screen is turned off, the upward eye (contralateral to the side the patient was lying on and either more or exclusively used for viewing the screen) is perceived to be blind for several minutes. Others have also described the apparently benign occurrence of transient monocular or binocular vision loss upon awakening, which may occur as the result of a similar autoregulatory failure during low-light conditions [
         <a href="#rid78">
          78,79
         </a>
         ]. It is prudent to consider this a diagnosis of exclusion and fully evaluate each patient as described below. (See
         <a class="local">
          'Diagnostic evaluation of transient visual loss'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H23">
         <span class="h2">
          Idiopathic
         </span>
         <span class="headingEndMark">
          —
         </span>
         Despite extensive workups, a cause of TMVL will not be found in some patients [
         <a href="#rid5">
          5,13,27
         </a>
         ]. These patients are at very low risk for either permanent visual loss or stroke and should be reassured.
        </p>
        <p>
         In one study, a higher proportion of 134 patients with TMVL were found to have Doppler evidence of jugular venous reflux compared with controls (57 versus 30 percent) [
         <a href="#rid80">
          80
         </a>
         ]. This was present in an even higher proportion (74 percent) of those with recurrent events of undetermined cause, suggesting that venous congestion may play a role in some cases of idiopathic TMVL.
        </p>
        <p class="headingAnchor" id="H24">
         <span class="h1">
          CAUSES OF TRANSIENT BINOCULAR VISUAL LOSS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Transient binocular visual loss (TBVL) implies a process posterior to the optic chiasm and may include migraine, seizure, and vertebrobasilar ischemia. Typical clinical features are summarized in the table  (
         <a class="graphic graphic_table graphicRef64994" href="/z/d/graphic/64994.html" rel="external">
          table 1
         </a>
         ). In rare cases, TBVL may reflect bilateral, simultaneous involvement of the anterior visual pathways such as might occur with giant cell arteritis (GCA) and systemic hypotension, as discussed above. Papilledema can produce unilateral or bilateral transient visual obscurations, also discussed above.
        </p>
        <p class="headingAnchor" id="H25">
         <span class="h2">
          Migraine
         </span>
         <span class="headingEndMark">
          —
         </span>
         Migraine is the most common cause of TBVL in young adults [
         <a href="#rid5">
          5
         </a>
         ]. Positive visual phenomena such as scintillations suggest migraine as the most likely diagnosis, especially if there is a history of headaches with migrainous features. (See
         <a class="medical medical_review" href="/z/d/html/5255.html" rel="external">
          "Approach to the patient with visual hallucinations"
         </a>
         .)
        </p>
        <p>
         This classic or typical migraine aura typically lasts 20 to 30 minutes, rarely as long as an hour, and has a characteristic build-up, or evolution, a feature lacking in other causes of TBVL (ischemia, seizure) [
         <a href="#rid81">
          81
         </a>
         ]. The mechanism of visual loss in migraine is thought to be neuronal depression after a period of cortical excitation ("spreading depression of Leao") [
         <a href="#rid82">
          82
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3348.html" rel="external">
          "Pathophysiology, clinical manifestations, and diagnosis of migraine in adults", section on 'Migraine aura'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3348.html" rel="external">
          "Pathophysiology, clinical manifestations, and diagnosis of migraine in adults", section on 'Pathophysiology'
         </a>
         .)
        </p>
        <p>
         Migraine visual aura may occur independently of headache (sometimes called migraine equivalent or acephalgic migraine) and may be confused with ischemia, especially in older patients [
         <a href="#rid14">
          14
         </a>
         ]. In a Danish study, 38 percent of 163 patients reported having attacks of migraine aura both with and without headache; 4 percent had migraine aura that never occurred with headache [
         <a href="#rid83">
          83
         </a>
         ]. The diagnosis of acephalgic migraine is supported by positive, binocular visual symptoms, a somewhat longer duration of episodes than is typical for ischemia, and a personal or strong family history of migraine [
         <a href="#rid14">
          14
         </a>
         ].
        </p>
        <p>
         Data from the Framingham cohort suggest that migrainous visual aura is not rare, even in older adults. In that study, 1.2 percent of individuals aged 50 to 82 years reported visual symptoms, subsequently attributed to migraine [
         <a href="#rid84">
          84
         </a>
         ]. In most (77 percent) of these 26 patients, the onset of these symptoms occurred after age 50 years; most episodes were never associated with headache (58 percent), and 42 percent had no history of recurrent headaches. Three strokes occurred subsequently in these 26 patients; this 11.5 percent incidence was lower than the 33 percent incidence among patients with transient ischemic attack (TIA).
        </p>
        <p class="headingAnchor" id="H26">
         <span class="h2">
          Seizure
         </span>
         <span class="headingEndMark">
          —
         </span>
         Visual seizure is an uncommon cause of TBVL. The visual loss may be ictal or postictal. (See
         <a class="medical medical_review" href="/z/d/html/2231.html" rel="external">
          "Focal epilepsy: Causes and clinical features", section on 'Occipital lobe epilepsy'
         </a>
         .)
        </p>
        <p>
         Among 20 patients in one series of epileptic visual aura, symptoms included elementary hallucinations (eg, flickering lights, stars, flashes of light) and visual loss, which was described as blurred vision, "white out," or scotomata [
         <a href="#rid85">
          85
         </a>
         ]. The visual loss and hallucinations could start in a specific part of the visual field, could move or be stationary, or could involve the entire visual field. These symptoms were not specifically localizing; underlying lesions (present in all) were found in either the occipital or temporal lobes. Ictal blindness may be an isolated epileptic phenomenon, but is more usually accompanied by other manifestations, such as tonic eye deviation, altered consciousness, or motor impairment [
         <a href="#rid86">
          86
         </a>
         ]. Prolonged ictal blindness ("status epilepticus amauroticus") is rarely reported [
         <a href="#rid87">
          87
         </a>
         ].
        </p>
        <p>
         Postictal blindness typically lasts minutes to hours but may last days or weeks. As with Todd paralysis (postictal weakness following a motor seizure), the mechanism is presumed to be prolonged enhancement of inhibitory stimuli in response to prolonged excitation (similar in some ways to migraine).
        </p>
        <p>
         Adult-onset visual seizures may be associated with cortical lesions in the posterior visual pathways, which produce a corresponding visual field defect. Therefore, visual field testing (preferably using static or kinetic perimetry) is important in all patients with TBVL.
        </p>
        <p class="headingAnchor" id="H27">
         <span class="h2">
          Vertebrobasilar ischemia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ischemia to the visual cortex may result in TBVL. If only one hemisphere is ischemic, the patient will experience homonymous visual field loss contralateral to the lesion. Visual loss may be an isolated symptom or may be accompanied by symptoms of brainstem ischemia (dysarthria, dysphagia, vertigo, diplopia) or cerebral ischemia (hemiparesis, hemisensory loss, aphasia). Isolated visual symptoms are usually the result of occipital lobe ischemia secondary to posterior cerebral artery occlusion. Difficulty seeing to one side is the most common symptom; lateralized flashing lights (photopsias) are also common [
         <a href="#rid88">
          88,89
         </a>
         ].
        </p>
        <p>
         As with anterior circulation ischemia, the mechanism of strokes in the posterior circulation may involve thrombosis, embolism, or hypoperfusion from fixed arterial stenosis [
         <a href="#rid90">
          90
         </a>
         ]. The most common identified mechanism underlying posterior cerebral artery territory infarcts is embolism, usually from cardiac disease [
         <a href="#rid91">
          91,92
         </a>
         ]. Artery to artery embolism, usually originating from proximal disease in the vertebral arteries, accounts for the second highest percentage. Atherostenosis in the posterior cerebral arteries has also been described [
         <a href="#rid88">
          88
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1102.html" rel="external">
          "Posterior circulation cerebrovascular syndromes", section on 'Posterior cerebral arteries'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H28">
         <span class="h1">
          DIAGNOSTIC EVALUATION OF TRANSIENT VISUAL LOSS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ischemia is the most common cause of transient monocular visual loss (TMVL) and also an important cause of transient binocular visual loss (TBVL). As many causes of retinal and optic nerve ischemia may also cause retinal infarction, optic nerve, or cerebral infarction, it is imperative to evaluate patients urgently so that the appropriate secondary preventive measures are instituted [
         <a href="#rid93">
          93
         </a>
         ]. While not specifically validated in patients with TMVL, the ABCD2 score may identify patients at higher risk for immediate (within seven days) ischemic stroke. Relevant features include older age, elevated blood pressure, duration of symptoms, and presence of diabetes. This is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/1088.html" rel="external">
          "Definition, etiology, and clinical manifestations of transient ischemic attack", section on 'Stroke risk stratification'
         </a>
         .)
        </p>
        <p>
         The diagnostic workup is tailored to the likely responsible conditions as suggested by the history and physical examination  (
         <a class="graphic graphic_table graphicRef64994" href="/z/d/graphic/64994.html" rel="external">
          table 1
         </a>
         ). The overlap in clinical presentations and grave prognosis of some potential diagnoses require that some diagnostic testing is performed in most patients. The evaluation prioritizes the diagnosis of ischemia in older patients and those with vascular risk factors  (
         <a class="graphic graphic_algorithm graphicRef111404" href="/z/d/graphic/111404.html" rel="external">
          algorithm 1
         </a>
         ).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Ophthalmologic evaluation
         </strong>
         – A detailed funduscopic evaluation is an important part of the evaluation of patients with transient visual loss (TVL). Ophthalmology referral is required for all patients with suspected giant cell arteritis (GCA), retinal vein disease, and ocular causes of visual loss, and will often reveal evidence of an otherwise unsuspected ischemic mechanism in patients with recurrent episodes of TMVL.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Erythrocyte sedimentation rate and C-reactive protein
         </strong>
         – All older patients (&gt;50 years) with transient monocular or binocular vision loss should have a sedimentation rate and C-reactive protein to exclude GCA. A complete blood count (CBC) is also helpful, as GCA is associated with thrombocytosis. If these are elevated, or if the history is very suggestive, patients should proceed to a confirmatory temporal artery biopsy. Treatment should not await pathology results. (See
         <a class="medical medical_review" href="/z/d/html/8225.html" rel="external">
          "Clinical manifestations of giant cell arteritis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8240.html" rel="external">
          "Treatment of giant cell arteritis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Carotid imaging
         </strong>
         – Carotid duplex ultrasound, magnetic resonance angiography (MRA), or computed tomographic angiography should be ordered in all older patients (&gt;50 years) and in younger patients with vascular risk factors (diabetes, hypertension, hyperlipidemia) who have experienced TMVL. Magnetic resonance imaging (MRI) should be performed in a patient of any age with TMVL who has a history suggestive of carotid artery dissection [
         <a href="#rid90">
          90
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Further evaluation and treatment of carotid disease in the setting of TMVL is discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/1118.html" rel="external">
          "Evaluation of carotid artery stenosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1106.html" rel="external">
          "Management of symptomatic carotid atherosclerotic disease"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cardiac evaluation
         </strong>
         – Once GCA and carotid disease have been excluded, an evaluation to seek a cardiogenic source of embolism should follow in all older patients (as well as in younger patients with risk factors) who have had TMVL. This is also indicated in patients with TBVL due to posterior circulation ischemia. Testing may include Holter monitoring and echocardiography [
         <a href="#rid94">
          94
         </a>
         ]. The details of this evaluation are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/1083.html" rel="external">
          "Overview of the evaluation of stroke", section on 'Cardiac evaluation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A baseline electrocardiogram (ECG) should also be included in the evaluation of these patients as cardiac morbidity and mortality in patients with TMVL and central retinal artery occlusion is significant [
         <a href="#rid17">
          17,30,95
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Brain MRI
         </strong>
         – Older patients with binocular visual symptoms (TBVL) that accompany symptoms suggestive of vertebrobasilar ischemia should have a brain MRI. Diffusion-weighted imaging (DWI) increases the yield of abnormalities in patients with TIA, and intracranial and cervical MRA may turn up occlusive disease of the posterior circulation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Patients with retinal artery occlusion also frequently have ischemic changes on DWI [
         <a href="#rid96">
          96
         </a>
         ]. Selected patients with TMVL whose mechanism remains uncertain following the above studies may benefit from having a brain MRI with DWI, as the presence of ischemic lesions may indicate a more vigorous assessment for less common causes of ischemia.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Patients whose history or examination suggests optic neuropathy should have an MRI to look for other evidence of demyelinating disease. A history suggestive of compressive optic neuropathy (gaze-evoked amaurosis) or seizure should also prompt a brain MRI with contrast enhancement.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          EEG
         </strong>
         – Electroencephalography (EEG) is not a routine test for TVL but should be undertaken in a patient with TBVL whose symptoms suggest possible seizure. EEG monitoring may increase the diagnostic yield, especially in patients with frequently recurring symptoms.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hypercoagulable testing
         </strong>
         – When brain or ocular ischemia is the suspected cause of TVL, hypercoagulable testing should be performed in individuals who have suggestive histories (prior thrombosis, miscarriage, or family history), as well as in individuals with probable ischemia and otherwise negative workup (see
         <a class="medical medical_review" href="/z/d/html/1363.html" rel="external">
          "Evaluating adult patients with established venous thromboembolism for acquired and inherited risk factors", section on 'Hypercoagulable tests'
         </a>
         ). A CBC should also be obtained to screen for conditions such as polycythemia vera and essential thrombocythemia.
        </p>
        <p>
        </p>
        <p>
         In young patients without vascular risk factors, evaluation can be more selective. Patients in whom there is a strong presumptive diagnosis of migraine may have a somewhat limited workup or perhaps no testing at all. An example might be a young person with typical binocular visual symptoms that include positive phenomena and are followed by migraine headache. Other factors that support (but obviously do not confirm) a diagnosis of migraine include a family history of migraine and a past history of migraine headaches. The more the symptoms deviate from classic migraine, the more extensive the workup should be.
        </p>
        <p>
         In the majority of young patients (&lt;50 years) with TMVL who are otherwise healthy, the diagnostic yield of extensive testing is very low [
         <a href="#rid4">
          4,97
         </a>
         ]. The most reasonable presumed cause is vasospasm or migraine, although this remains speculative. Their future risk of stroke is low [
         <a href="#rid98">
          98
         </a>
         ]. However, TMVL due to carotid disease and cardiac disease does occur in young people [
         <a href="#rid3">
          3,95
         </a>
         ]. The extent to which these patients should be subjected to diagnostic investigation is debated and should be decided individually. A conservative approach recommends performing noninvasive studies that identify high-risk pathology. This might include MRI, carotid imaging, ECG, echocardiography, and selective clotting studies [
         <a href="#rid1">
          1,3,70,95
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H30">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Causes
         </strong>
         – Underlying causes of transient visual loss (TVL) range from benign conditions to those with serious neurologic and ophthalmologic sequelae.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Transient monocular vision loss
         </strong>
         – Ischemia originating from carotid artery disease is a common cause of transient monocular visual loss (TMVL) and has serious implications for future stroke risk that can be reduced by carotid endarterectomy. Suggestive features include rapid onset in an altitudinal pattern (visual loss descending over the field of vision like a curtain or shade) and brief duration (&lt;10 minutes). (See
         <a class="local">
          'Carotid artery disease'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Giant cell arteritis (GCA) is not a common cause of TMVL but is a treatable cause of otherwise permanent visual loss. It is clinically indistinguishable from TMVL of carotid disease except for frequent accompanying headache. (See
         <a class="local">
          'Giant cell arteritis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Other causes of TMVL include ischemia from cardioembolic disease, some ocular conditions, and others. (See
         <a class="local">
          'Causes of transient monocular visual loss'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         TMVL in young patients may be due to retinal vasospasm or may be idiopathic, but other etiologies must be excluded. (See
         <a class="local">
          'Retinal vasospasm and retinal migraine'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Transient binocular vision loss
         </strong>
         – Migraine typically produces binocular symptoms with positive phenomenology and a characteristic build-up, lasting 10 to 30 minutes, and associated with or followed by migraine headache. (See
         <a class="local">
          'Migraine'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Binocular visual loss, usually isolated to one visual field, can also occur during vertebrobasilar ischemia or seizure. (See
         <a class="local">
          'Causes of transient binocular visual loss'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnostic approach
         </strong>
         – With transient symptoms, the diagnosis is guided by historical features. The most important of these is the distinction between monocular and binocular involvement; however, this is often unclear. Other helpful features include symptom duration, description of symptom onset, the presence of positive visual phenomena, precipitating factors, and associated symptoms  (
         <a class="graphic graphic_table graphicRef64994" href="/z/d/graphic/64994.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Historical features'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnostic testing
         </strong>
         – Some diagnostic testing is required in most patients; an exception is a young patient with normal examination, typical migrainous features, and no vascular risk factors. Erythrocyte sedimentation rate and C-reactive protein should be performed in all individuals over age 50 years with transient monocular or binocular visual loss.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         We recommend ophthalmologic examination and carotid duplex ultrasound for patients with TMVL if they are &gt;50 years and/or have vascular risk factors  (
         <a class="graphic graphic_algorithm graphicRef111404" href="/z/d/graphic/111404.html" rel="external">
          algorithm 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Other tests are ordered according to symptoms and clinical setting and may include cardiac workup, hypercoagulable testing, MRI, and EEG  (
         <a class="graphic graphic_table graphicRef78246" href="/z/d/graphic/78246.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="local">
          'Diagnostic evaluation of transient visual loss'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li class="breakAll">
          Bernstein EF. Amaurosis fugax, Springer-Verlag, 1987. p.286.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fisher CM. 'Transient monocular blindness' versus 'amaurosis fugax'. Neurology 1989; 39:1622.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Biousse V, Trobe JD. Transient monocular visual loss. Am J Ophthalmol 2005; 140:717.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tippin J, Corbett JJ, Kerber RE, et al. Amaurosis fugax and ocular infarction in adolescents and young adults. Ann Neurol 1989; 26:69.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lavallée PC, Cabrejo L, Labreuche J, et al. Spectrum of transient visual symptoms in a transient ischemic attack cohort. Stroke 2013; 44:3312.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Donders RC, Dutch TMB Study Group. Clinical features of transient monocular blindness and the likelihood of atherosclerotic lesions of the internal carotid artery. J Neurol Neurosurg Psychiatry 2001; 71:247.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pessin MS, Duncan GW, Mohr JP, Poskanzer DC. Clinical and angiographic features of carotid transient ischemic attacks. N Engl J Med 1977; 296:358.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marshall J, Meadows S. The natural history of amaurosis fugax. Brain 1968; 91:419.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Burde RM. Amaurosis fugax. An overview. J Clin Neuroophthalmol 1989; 9:185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Richard KT, Chan L, Fleming JF, et al. for the NASCET Group, London, Ontario Canada. Neurology 1996; 46:A392.
          </a>
         </li>
         <li class="breakAll">
          Hoyt WF. Ocular symptoms and signs. In: Extracranial Occlusive Cerebrovascular Disease Diagnosis and Management, Wylie EJ, Ehrenfeld W (Eds), WB Saunders, Philadelphia 1970. p.64.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lord RS. Transient monocular blindness. Aust N Z J Ophthalmol 1990; 18:299.
          </a>
         </li>
         <li class="breakAll">
          Newman NJ. Cerebrovascular disease. In: Walsh and Hoyt's Clinical Neuro-ophthalmology, 5th ed, Miller NR, Newman NJ (Eds), Lippincott, Williams &amp; Wilkins, Baltimore 1998. p.3323.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fisher CM. Late-life migraine accompaniments as a cause of unexplained transient ischemic attacks. Can J Neurol Sci 1980; 7:9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kosmorsky GS, Rosenfeld SI, Burde RM. Transient monocular obscuration--?amaurosis fugax: a case report. Br J Ophthalmol 1985; 69:688.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Russell RW, Page NG. Critical perfusion of brain and retina. Brain 1983; 106 (Pt 2):419.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaiboriboon K, Piriyawat P, Selhorst JB. Light-induced amaurosis fugax. Am J Ophthalmol 2001; 131:674.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Furlan AJ, Whisnant JP, Kearns TP. Unilateral visual loss in bright light. An unusual symptom of carotid artery occlusive disease. Arch Neurol 1979; 36:675.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Galetta SL, Balcer LJ, Liu GT. Giant cell arteritis with unusual flow-related neuro-ophthalmologic manifestations. Neurology 1997; 49:1463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levin LA, Mootha VV. Postprandial transient visual loss. A symptom of critical carotid stenosis. Ophthalmology 1997; 104:397.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Knapp ME, Flaharty PM, Sergott RC, et al. Gaze-induced amaurosis from central retinal artery compression. Ophthalmology 1992; 99:238.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jehn A, Frank Dettwiler B, Fleischhauer J, et al. Exercise-induced vasospastic amaurosis fugax. Arch Ophthalmol 2002; 120:220.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Imes RK, Hoyt WF. Exercise-induced transient visual events in young healthy adults. J Clin Neuroophthalmol 1989; 9:178.
          </a>
         </li>
         <li class="breakAll">
          Miller NR. Embolic causes of transient monocular visual loss: Appearance, source, and assessment. In: Ophthalmology Clinics of North America, Katz B (Ed), W.B. Saunders, Philadelphia 1996. p.359.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cugati S, Wang JJ, Rochtchina E, Mitchell P. Ten-year incidence of retinal emboli in an older population. Stroke 2006; 37:908.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang JJ, Cugati S, Knudtson MD, et al. Retinal arteriolar emboli and long-term mortality: pooled data analysis from two older populations. Stroke 2006; 37:1833.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Current management of amaurosis fugax. The Amaurosis Fugax Study Group. Stroke 1990; 21:201.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anderson DC, Kappelle LJ, Eliasziw M, et al. Occurrence of hemispheric and retinal ischemia in atrial fibrillation compared with carotid stenosis. Stroke 2002; 33:1963.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mead GE, Lewis SC, Wardlaw JM, Dennis MS. Comparison of risk factors in patients with transient and prolonged eye and brain ischemic syndromes. Stroke 2002; 33:2383.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hurwitz BJ, Heyman A, Wilkinson WE, et al. Comparison of amaurosis fugax and transient cerebral ischemia: a prospective clinical and arteriographic study. Ann Neurol 1985; 18:698.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           North American Symptomatic Carotid Endarterectomy Trial Collaborators, Barnett HJM, Taylor DW, et al. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325:445.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bruno A, Corbett JJ, Biller J, et al. Transient monocular visual loss patterns and associated vascular abnormalities. Stroke 1990; 21:34.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilterdink JL, Easton JD. Vascular event rates in patients with atherosclerotic cerebrovascular disease. Arch Neurol 1992; 49:857.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De Schryver EL, Algra A, Donders RC, et al. Type of stroke after transient monocular blindness or retinal infarction of presumed arterial origin. J Neurol Neurosurg Psychiatry 2006; 77:734.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Benavente O, Eliasziw M, Streifler JY, et al. Prognosis after transient monocular blindness associated with carotid-artery stenosis. N Engl J Med 2001; 345:1084.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol 1998; 125:509.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hayreh SS, Podhajsky PA, Zimmerman B. Occult giant cell arteritis: ocular manifestations. Am J Ophthalmol 1998; 125:521.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Caselli RJ, Hunder GG, Whisnant JP. Neurologic disease in biopsy-proven giant cell (temporal) arteritis. Neurology 1988; 38:352.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wells M, Foroozan R. Transient visual loss may anticipate occipital infarction from hemodialysis. Am J Kidney Dis 2004; 43:e29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Luchi M, Warren KA, Saberhagen C, Hinthorn D. Transient visual loss due to severe anemia in a patient with AIDS. J La State Med Soc 1999; 151:82.
          </a>
         </li>
         <li class="breakAll">
          Biousse V. Cerebrovascular disease. In: Walsh and Hoyt's Clinical Neuro-ophthalmology, 6th ed, Miller NR, Newman NJ, Biousse V, Kerrison JB (Eds), Williams and Wilkins, Baltimore 2005. Vol 2, p.1967.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tatemichi TK, Chamorro A, Petty GW, et al. Hemodynamic role of ophthalmic artery collateral in internal carotid artery occlusion. Neurology 1990; 40:461.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mimura T, Funatsu H, Kitano S, et al. Diabetic retinopathy with repeated amaurosis fugax caused by orthostatic hypotension. Am J Ophthalmol 2003; 136:930.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schlingemann RO, Smit AA, Lunel HF, Hijdra A. Amaurosis fugax on standing and angle-closure glaucoma with clomipramine. Lancet 1996; 347:465.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Asherson RA, Cervera R. Unusual manifestations of the antiphospholipid syndrome. Clin Rev Allergy Immunol 2003; 25:61.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Digre KB, Durcan FJ, Branch DW, et al. Amaurosis fugax associated with antiphospholipid antibodies. Ann Neurol 1989; 25:228.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glueck CJ, Goldenberg N, Bell H, et al. Amaurosis fugax: associations with heritable thrombophilia. Clin Appl Thromb Hemost 2005; 11:235.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fry CL, Carter JE, Kanter MC, et al. Anterior ischemic optic neuropathy is not associated with carotid artery atherosclerosis. Stroke 1993; 24:539.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Terao S, Takeda A, Miura N, et al. Clinical and pathophysiological features of amaurosis fugax in Japanese stroke patients. Intern Med 2000; 39:118.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cackett P, Weir C. Wegener's granulomatosis presenting with amaurosis fugax. Eye (Lond) 2002; 16:676.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Libman RB, Masters SR, de Paola A, Mohr JP. Transient monocular blindness associated with cocaine abuse. Neurology 1993; 43:228.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ubogu E. Amaurosis fugax associated with phencyclidine inhalation. Eur Neurol 2001; 46:98.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pece A, Patelli F, Milani P, Pierro L. Transient visual loss after amyl Isobutyl nitrite abuse. Semin Ophthalmol 2004; 19:105.
          </a>
         </li>
         <li class="breakAll">
          Hayreh SS. Central retinal vein occlusion. In: The Eye and Systemic Disease, 2nd ed, Mausolf FA (Ed), CV Mosby, St. Louis 1980. p.223.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shuler RK Jr, Biousse V, Newman NJ. Transient monocular visual loss in two patients with impending central retinal vein occlusion. J Neuroophthalmol 2005; 25:152.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prisco D, Marcucci R. Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach. Pathophysiol Haemost Thromb 2002; 32:308.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Biousse V, Newman NJ, Sternberg P Jr. Retinal vein occlusion and transient monocular visual loss associated with hyperhomocystinemia. Am J Ophthalmol 1997; 124:257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cugati S, Wang JJ, Knudtson MD, et al. Retinal vein occlusion and vascular mortality: pooled data analysis of 2 population-based cohorts. Ophthalmology 2007; 114:520.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Sullivan F, Rossor M, Elston JS. Amaurosis fugax in young people. Br J Ophthalmol 1992; 76:660.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Slavin ML. Amaurosis fugax in the young. Surv Ophthalmol 1997; 41:481.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Burger SK, Saul RF, Selhorst JB, Thurston SE. Transient monocular blindness caused by vasospasm. N Engl J Med 1991; 325:870.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Winterkorn JM, Teman AJ. Recurrent attacks of amaurosis fugax treated with calcium channel blocker. Ann Neurol 1991; 30:423.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heckmann JG, Gaul C, Neundörfer B, et al. Vasospastic amaurosis fugax. J Neurol Neurosurg Psychiatry 2003; 74:149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bernard GA, Bennett JL. Vasospastic amaurosis fugax. Arch Ophthalmol 1999; 117:1568.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004; 24suppl1:9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Winterkorn JM, Kupersmith MJ, Wirtschafter JD, Forman S. Brief report: treatment of vasospastic amaurosis fugax with calcium-channel blockers. N Engl J Med 1993; 329:396.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Flammer J, Pache M, Resink T. Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Retin Eye Res 2001; 20:319.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith KJ, McDonald WI. The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease. Philos Trans R Soc Lond B Biol Sci 1999; 354:1649.
          </a>
         </li>
         <li class="breakAll">
          Beck RW. Optic Neuritis. In: Walsh and Hoyt's Clinical Neuro-ophthalmology, 5th ed, Miller NR, Newman NJ (Eds), Lippincott, Williams &amp; Wilkins, Baltimore 1998. p.599.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lepore FE. Uhthoff's symptom in disorders of the anterior visual pathways. Neurology 1994; 44:1036.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sadun AA, Currie JN, Lessell S. Transient visual obscurations with elevated optic discs. Ann Neurol 1984; 16:489.
          </a>
         </li>
         <li class="breakAll">
          Miller NR. Papilledema. In: Walsh and Hoyt's Clinical Neuro-ophthalmology, 5th ed, Miller NR, Newman NJ (Eds), Lippincott, Williams &amp; Wilkins, Baltimore 1998. p.487.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Otto CS, Coppit GL, Mazzoli RA, et al. Gaze-evoked amaurosis: a report of five cases. Ophthalmology 2003; 110:322.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khan MA, Dhillon B. Epiphora due to Kaposi's sarcoma of the nasolacrimal duct. Br J Ophthalmol 1999; 83:501.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ravits J, Seybold ME. Transient monocular visual loss from narrow-angle glaucoma. Arch Neurol 1984; 41:991.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cates CA, Newman DK. Transient monocular visual loss due to uveitis-glaucoma-hyphaema (UGH) syndrome. J Neurol Neurosurg Psychiatry 1998; 65:131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alim-Marvasti A, Bi W, Mahroo OA, et al. Transient Smartphone "Blindness". N Engl J Med 2016; 374:2502.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bouffard MA, Cornblath WT, Rizzo JF 3rd, et al. Transient Monocular Vision Loss on Awakening: A Benign Amaurotic Phenomenon. J Neuroophthalmol 2017; 37:122.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sanchez Moreno FR, Mansukhani SA, Bhatti MT, Chen JJ. Transient Bilateral Central Scotoma on Awakening: A Distinct Phenomenon. J Neuroophthalmol 2023; 43:209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hsu HY, Chao AC, Chen YY, et al. Reflux of jugular and retrobulbar venous flow in transient monocular blindness. Ann Neurol 2008; 63:247.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004; 24 Suppl 1:9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leao AA. Spreading depression of activity in the cerebral cortex. J Neurophysiol 1944; 7:359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Russell MB, Olesen J. A nosographic analysis of the migraine aura in a general population. Brain 1996; 119 ( Pt 2):355.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wijman CA, Wolf PA, Kase CS, et al. Migrainous visual accompaniments are not rare in late life: the Framingham Study. Stroke 1998; 29:1539.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bien CG, Benninger FO, Urbach H, et al. Localizing value of epileptic visual auras. Brain 2000; 123 ( Pt 2):244.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sadeh M, Goldhammer Y, Kuritsky A. Postictal blindness in adults. J Neurol Neurosurg Psychiatry 1983; 46:566.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barry E, Sussman NM, Bosley TM, Harner RN. Ictal blindness and status epilepticus amauroticus. Epilepsia 1985; 26:577.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pessin MS, Kwan ES, DeWitt LD, et al. Posterior cerebral artery stenosis. Ann Neurol 1987; 21:85.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tierney MC, Reid DW, Zorzitto ML, et al. The differential diagnosis of Alzheimer's disease: conceptual and methodological issues. Can J Neurol Sci 1986; 13:424.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Biousse V, Touboul PJ, D'Anglejan-Chatillon J, et al. Ophthalmologic manifestations of internal carotid artery dissection. Am J Ophthalmol 1998; 126:565.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Caplan LR, Wityk RJ, Glass TA, et al. New England Medical Center Posterior Circulation registry. Ann Neurol 2004; 56:389.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Belden JR, Caplan LR, Pessin MS, Kwan E. Mechanisms and clinical features of posterior border-zone infarcts. Neurology 1999; 53:1312.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Biousse V. Acute retinal arterial ischemia: an emergency often ignored. Am J Ophthalmol 2014; 157:1119.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kramer M, Goldenberg-Cohen N, Shapira Y, et al. Role of transesophageal echocardiography in the evaluation of patients with retinal artery occlusion. Ophthalmology 2001; 108:1461.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kline LB. The natural history of patients with amaurosis fugax. Ophthal Clin North Am 1996; 9:351.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee J, Kim SW, Lee SC, et al. Co-occurrence of acute retinal artery occlusion and acute ischemic stroke: diffusion-weighted magnetic resonance imaging study. Am J Ophthalmol 2014; 157:1231.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Newman NJ. Evaluating the patient with transient monocular vision loss: the young vs the elderly. Ophthalmol Clin North Am 1996; 9:455.
          </a>
         </li>
         <li class="breakAll">
          Biousse V. Cerebrovascular disease. In: Walsh and Hoyt's Clinical Neuro-ophthalmology, 6th ed, Miller NR, Newman NJ, Biousse V, Kerrison JB (Eds), Williams and Wilkins, 2005. Vol 2, p.1967.
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5245 Version 17.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Bernstein EF. Amaurosis fugax, Springer-Verlag, 1987. p.286.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2685658" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : 'Transient monocular blindness' versus 'amaurosis fugax'.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16140247" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Transient monocular visual loss.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2774503" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Amaurosis fugax and ocular infarction in adolescents and young adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24178913" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Spectrum of transient visual symptoms in a transient ischemic attack cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11459904" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Clinical features of transient monocular blindness and the likelihood of atherosclerotic lesions of the internal carotid artery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/834199" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Clinical and angiographic features of carotid transient ischemic attacks.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5723016" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : The natural history of amaurosis fugax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2529279" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Amaurosis fugax. An overview.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : for the NASCET Group, London, Ontario Canada
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : for the NASCET Group, London, Ontario Canada
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2261177" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Transient monocular blindness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2261177" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Transient monocular blindness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7388704" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Late-life migraine accompaniments as a cause of unexplained transient ischemic attacks.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4041415" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Transient monocular obscuration--?amaurosis fugax: a case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6850276" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Critical perfusion of brain and retina.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11336956" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Light-induced amaurosis fugax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/508123" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Unilateral visual loss in bright light. An unusual symptom of carotid artery occlusive disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9371944" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Giant cell arteritis with unusual flow-related neuro-ophthalmologic manifestations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9082262" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Postprandial transient visual loss. A symptom of critical carotid stenosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1553214" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Gaze-induced amaurosis from central retinal artery compression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11831932" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Exercise-induced vasospastic amaurosis fugax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2529277" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Exercise-induced transient visual events in young healthy adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2529277" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Exercise-induced transient visual events in young healthy adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16439697" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Ten-year incidence of retinal emboli in an older population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16741179" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Retinal arteriolar emboli and long-term mortality: pooled data analysis from two older populations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2406992" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Current management of amaurosis fugax. The Amaurosis Fugax Study Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12154246" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Occurrence of hemispheric and retinal ischemia in atrial fibrillation compared with carotid stenosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12364725" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Comparison of risk factors in patients with transient and prolonged eye and brain ischemic syndromes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4083852" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Comparison of amaurosis fugax and transient cerebral ischemia: a prospective clinical and arteriographic study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1852179" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2300989" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Transient monocular visual loss patterns and associated vascular abnormalities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1524519" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Vascular event rates in patients with atherosclerotic cerebrovascular disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16500944" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Type of stroke after transient monocular blindness or retinal infarction of presumed arterial origin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11596587" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Prognosis after transient monocular blindness associated with carotid-artery stenosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9559737" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Ocular manifestations of giant cell arteritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9559738" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Occult giant cell arteritis: ocular manifestations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3347337" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Neurologic disease in biopsy-proven giant cell (temporal) arteritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15112196" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Transient visual loss may anticipate occipital infarction from hemodialysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11280841" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Transient visual loss due to severe anemia in a patient with AIDS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11280841" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Transient visual loss due to severe anemia in a patient with AIDS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2179762" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Hemodynamic role of ophthalmic artery collateral in internal carotid artery occlusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14597053" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Diabetic retinopathy with repeated amaurosis fugax caused by orthostatic hypotension.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8618496" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Amaurosis fugax on standing and angle-closure glaucoma with clomipramine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12794262" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Unusual manifestations of the antiphospholipid syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2729913" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Amaurosis fugax associated with antiphospholipid antibodies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16015408" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Amaurosis fugax: associations with heritable thrombophilia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8465359" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Anterior ischemic optic neuropathy is not associated with carotid artery atherosclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10732827" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Clinical and pathophysiological features of amaurosis fugax in Japanese stroke patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12194103" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Wegener's granulomatosis presenting with amaurosis fugax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8423897" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Transient monocular blindness associated with cocaine abuse.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11528160" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Amaurosis fugax associated with phencyclidine inhalation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15590547" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Transient visual loss after amyl Isobutyl nitrite abuse.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15590547" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Transient visual loss after amyl Isobutyl nitrite abuse.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15937443" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Transient monocular visual loss in two patients with impending central retinal vein occlusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13679663" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9262559" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Retinal vein occlusion and transient monocular visual loss associated with hyperhomocystinemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17141315" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Retinal vein occlusion and vascular mortality: pooled data analysis of 2 population-based cohorts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1477040" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Amaurosis fugax in young people.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9220571" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Amaurosis fugax in the young.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1875972" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Transient monocular blindness caused by vasospasm.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1952830" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Recurrent attacks of amaurosis fugax treated with calcium channel blocker.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12531936" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Vasospastic amaurosis fugax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10565534" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Vasospastic amaurosis fugax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : The International Classification of Headache Disorders: 2nd edition
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8326973" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Brief report: treatment of vasospastic amaurosis fugax with calcium-channel blockers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11286896" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10603618" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10603618" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8208395" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Uhthoff's symptom in disorders of the anterior visual pathways.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6497356" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Transient visual obscurations with elevated optic discs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6497356" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Transient visual obscurations with elevated optic discs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12578775" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Gaze-evoked amaurosis: a report of five cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10454797" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Epiphora due to Kaposi's sarcoma of the nasolacrimal duct.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6477235" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Transient monocular visual loss from narrow-angle glaucoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9667576" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Transient monocular visual loss due to uveitis-glaucoma-hyphaema (UGH) syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27332920" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Transient Smartphone "Blindness".
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27749399" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Transient Monocular Vision Loss on Awakening: A Benign Amaurotic Phenomenon.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36255080" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Transient Bilateral Central Scotoma on Awakening: A Distinct Phenomenon.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18306412" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Reflux of jugular and retrobulbar venous flow in transient monocular blindness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14979299" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : The International Classification of Headache Disorders: 2nd edition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Spreading depression of activity in the cerebral cortex
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8800932" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : A nosographic analysis of the migraine aura in a general population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9707189" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Migrainous visual accompaniments are not rare in late life: the Framingham Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10648433" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Localizing value of epileptic visual auras.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6410006" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Postictal blindness in adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4076063" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Ictal blindness and status epilepticus amauroticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3827217" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Posterior cerebral artery stenosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3791057" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : The differential diagnosis of Alzheimer's disease: conceptual and methodological issues.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9780102" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Ophthalmologic manifestations of internal carotid artery dissection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15349866" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : New England Medical Center Posterior Circulation registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10522890" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Mechanisms and clinical features of posterior border-zone infarcts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24881836" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Acute retinal arterial ischemia: an emergency often ignored.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11470701" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Role of transesophageal echocardiography in the evaluation of patients with retinal artery occlusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : The natural history of patients with amaurosis fugax
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24503410" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Co-occurrence of acute retinal artery occlusion and acute ischemic stroke: diffusion-weighted magnetic resonance imaging study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Evaluating the patient with transient monocular vision loss: the young vs the elderly
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
